Literature DB >> 11687900

Downmodulation of bFGF-binding protein expression following restoration of p53 function.

Z A Sherif1, S Nakai, K F Pirollo, A Rait, E H Chang.   

Abstract

Angiogenesis is a requirement for solid tumor growth. Therefore, inhibition of this neovascularization is one mechanism by which restoration of wtp53 function may lead to tumor regression. Here we report that adenoviral vector-mediated wild-type p53 transduction results in growth inhibition of squamous cell carcinoma of the head and neck tumor cells both in vitro and in a xenograft mouse model. This growth inhibition is associated with the down-regulation of the expression of fibroblast growth factor binding protein, a secreted protein required for the activation of angiogenic factor basic FGF. These findings suggest that wtp53-induced tumor regression is due, at least in part, to antiangiogenesis mediated by the downmodulation of fibroblast growth factor binding protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687900     DOI: 10.1038/sj.cgt.7700361

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  7 in total

1.  Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.

Authors:  Gangjian Qin; Raj Kishore; Christine M Dolan; Marcy Silver; Andrea Wecker; Corinne N Luedemann; Tina Thorne; Allison Hanley; Cynthia Curry; Lindsay Heyd; Deepika Dinesh; Marianne Kearney; Fabio Martelli; Toshinori Murayama; David A Goukassian; Yan Zhu; Douglas W Losordo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-11       Impact factor: 11.205

Review 2.  Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome.

Authors:  Jose G Teodoro; Sara K Evans; Michael R Green
Journal:  J Mol Med (Berl)       Date:  2007-06-23       Impact factor: 4.599

3.  Divergent control of Cav-1 expression in non-cancerous Li-Fraumeni syndrome and human cancer cell lines.

Authors:  Zaki A Sherif; Ahmed S Sultan
Journal:  Cancer Biol Ther       Date:  2012-10-31       Impact factor: 4.742

Review 4.  Mechanism and its regulation of tumor-induced angiogenesis.

Authors:  Manoj Kumar Gupta; Ren-Yi Qin
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

Review 5.  Current status and perspective of antiangiogenic therapy for cancer: urinary cancer.

Authors:  Shigeru Kanda; Yasuyoshi Miyata; Hiroshi Kanetake
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.850

6.  Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer.

Authors:  L A Akslen; O Straume; S Geisler; T Sørlie; J-T Chi; T Aas; A-L Børresen-Dale; P E Lønning
Journal:  Br J Cancer       Date:  2011-06-14       Impact factor: 7.640

7.  Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP) knockdown in colon carcinoma.

Authors:  Daniel Schulze; Philipp Plohmann; Sabrina Höbel; Achim Aigner
Journal:  Mol Cancer       Date:  2011-11-23       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.